Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare TSE:AUP NYSE:BHC CVE:PYR NASDAQ:SLS On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAUPAurinia PharmaceuticalsC$0.00C$11.77▼C$26.00C$2.15BN/A229,895 shs4.61 million shsBHCBausch Health Cos$4.43-0.6%$5.00$4.33▼$8.69$1.66B0.422.60 million shs1.23 million shsPYRPyroGenesis Canada Inc. (PYR.V)C$3.85+11.0%C$3.85C$0.19▼C$6.43C$606.96MN/A337,985 shs335,425 shsSLSSELLAS Life Sciences Group$11.32-8.3%$10.36$1.39▼$15.88$2.43B2.4210.68 million shs6.71 million shs10 Best Stocks to Own - Summer 2026Enter your email address and we’ll send you MarketBeat’s list of ten stocks set to soar in Summer 2026, despite the threat of tariffs and what's happening in Iran. These ten stocks are incredibly resilient and are likely to thrive in any economic environment. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAUPAurinia Pharmaceuticals0.00%0.00%0.00%0.00%0.00%BHCBausch Health Cos-0.67%-8.86%-11.23%-21.33%-33.41%PYRPyroGenesis Canada Inc. (PYR.V)0.00%0.00%0.00%0.00%0.00%SLSSELLAS Life Sciences Group-8.27%-14.18%+23.45%+153.81%+515.22%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAUPAurinia PharmaceuticalsC$0.00C$11.77▼C$26.00C$2.15BN/A229,895 shs4.61 million shsBHCBausch Health Cos$4.43-0.6%$5.00$4.33▼$8.69$1.66B0.422.60 million shs1.23 million shsPYRPyroGenesis Canada Inc. (PYR.V)C$3.85+11.0%C$3.85C$0.19▼C$6.43C$606.96MN/A337,985 shs335,425 shsSLSSELLAS Life Sciences Group$11.32-8.3%$10.36$1.39▼$15.88$2.43B2.4210.68 million shs6.71 million shs10 Best Stocks to Own - Summer 2026Enter your email address and we’ll send you MarketBeat’s list of ten stocks set to soar in Summer 2026, despite the threat of tariffs and what's happening in Iran. These ten stocks are incredibly resilient and are likely to thrive in any economic environment. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAUPAurinia Pharmaceuticals0.00%0.00%0.00%0.00%0.00%BHCBausch Health Cos-0.67%-8.86%-11.23%-21.33%-33.41%PYRPyroGenesis Canada Inc. (PYR.V)0.00%0.00%0.00%0.00%0.00%SLSSELLAS Life Sciences Group-8.27%-14.18%+23.45%+153.81%+515.22%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAUPAurinia Pharmaceuticals 0.00N/AN/AN/ABHCBausch Health Cos 1.83Reduce$8.0080.79% UpsidePYRPyroGenesis Canada Inc. (PYR.V) 0.00N/AN/AN/ASLSSELLAS Life Sciences Group 2.33Hold$10.00-11.66% DownsideCurrent Analyst Ratings BreakdownLatest PYR, BHC, AUP, and SLS Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails7/22/2026BHCBausch Health Cos Jefferies Financial GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeHold7/17/2026SLSSELLAS Life Sciences Group Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D-)7/6/2026SLSSELLAS Life Sciences Group Alliance Global PartnersSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy5/4/2026BHCBausch Health Cos Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeSell (D) ➝ Sell (D-)4/27/2026BHCBausch Health Cos Royal Bank Of CanadaSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetSector Perform$10.00 ➝ $9.00(Data available from 7/25/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAUPAurinia PharmaceuticalsC$57.59M0.00N/A6.75C$2.59 per share0.00BHCBausch Health Cos$10.53B0.16$7.25 per share0.61$1.02 per share4.34PYRPyroGenesis Canada Inc. (PYR.V)C$6.01M100.97C$0.01 per share294.62C$0.02 per share183.33SLSSELLAS Life Sciences GroupN/AN/AN/AN/A$0.46 per shareN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAUPAurinia PharmaceuticalsN/A-C$1.48N/AN/AN/AN/AN/AN/AN/ABHCBausch Health Cos$157M-$3.24N/A1.22N/A-11.47%-2,922.77%5.63%7/29/2026 (Estimated)PYRPyroGenesis Canada Inc. (PYR.V)N/A-C$0.03N/AN/AN/AN/AN/AN/AN/ASLSSELLAS Life Sciences Group-$26.86M-$0.23N/AN/AN/AN/A-47.12%-42.63%8/11/2026 (Estimated)Latest PYR, BHC, AUP, and SLS EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/11/2026Q2 2026SLSSELLAS Life Sciences Group-$0.0450N/AN/AN/AN/AN/A7/29/2026Q2 2026BHCBausch Health Cos$0.96N/AN/AN/A$2.59 billionN/A5/12/2026Q1 2026SLSSELLAS Life Sciences Group-$0.06-$0.05+$0.01-$0.05N/AN/A4/29/2026Q1 2026BHCBausch Health Cos$0.81$0.78-$0.03-$3.76$2.37 billion$2.46 billionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthAUPAurinia PharmaceuticalsN/AN/AN/AN/AN/ABHCBausch Health CosN/AN/AN/AN/AN/APYRPyroGenesis Canada Inc. (PYR.V)N/AN/AN/AN/AN/ASLSSELLAS Life Sciences GroupN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAUPAurinia Pharmaceuticals2.6911.9311.02BHCBausch Health Cos54.681.320.97PYRPyroGenesis Canada Inc. (PYR.V)165.500.320.32SLSSELLAS Life Sciences GroupN/A17.2217.22Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAUPAurinia PharmaceuticalsN/ABHCBausch Health Cos78.65%PYRPyroGenesis Canada Inc. (PYR.V)N/ASLSSELLAS Life Sciences Group17.38%Insider OwnershipCompanyInsider OwnershipAUPAurinia PharmaceuticalsN/ABHCBausch Health Cos20.67%PYRPyroGenesis Canada Inc. (PYR.V)N/ASLSSELLAS Life Sciences Group1.30%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAUPAurinia Pharmaceuticals300128.40 millionN/ANot OptionableBHCBausch Health Cos20,300374.03 million296.72 millionOptionablePYRPyroGenesis Canada Inc. (PYR.V)90157.65 millionN/ANot OptionableSLSSELLAS Life Sciences Group10196.63 million194.08 millionNot OptionablePYR, BHC, AUP, and SLS HeadlinesRecent News About These CompaniesSellas CEO Angelos Stergiou says '100% certain' AI can be used to beat cancerJuly 24 at 12:09 PM | msn.comSLS stock rises overnight: Retail traders call new AML survival data 'huge' ahead of CEO’s Fox appearanceJuly 24 at 12:09 PM | msn.comSLS stock July rout deepens: 'Pharma Bro' Martin Shkreli questions timing of AML trial, says data may wait until ChristmasJuly 23 at 10:46 AM | msn.comSELLAS Life Sciences Group (NASDAQ:SLS) Shares Down 6.3% - What's Next?July 22 at 11:59 AM | marketbeat.comSLS stock tracks worst month since March: Investor slashes stake by over 30% as quiet period begins ahead of AML readoutJuly 22 at 1:24 AM | msn.comSLS stock rises overnight: Retail thinks CEO just dropped buyout clues ahead of Fox appearanceJuly 21, 2026 | msn.comSELLAS Life Sciences Group (NASDAQ:SLS) & Abivax (NASDAQ:ABVX) Critical ComparisonJuly 21, 2026 | americanbankingnews.comSLS stock hits July low as AML readout nears — retail bulls see 'stellar' hint in CEO's Fox appearance next weekJuly 18, 2026 | msn.comSELLAS Life Sciences Group (SLS) Stock Looks Rich On Book Value Yet Strong On ReturnsJuly 18, 2026 | finance.yahoo.comSELLAS Life Sciences rebounds 12% as investors continue to wait for key dataJuly 18, 2026 | seekingalpha.comSELLAS Life Sciences Group (SLS) Stock Pricey Following Phase 3 Trial BuzzJuly 18, 2026 | finance.yahoo.comSellas Life (SLS) Climbs 12% Ahead of ‘Potentially Company-Defining’ Clinical Trial ResultJuly 17, 2026 | insidermonkey.comSELLAS Life Sciences Group (NASDAQ:SLS) Shares Up 13.1% - Still a Buy?July 17, 2026 | marketbeat.comSELLAS Life Sciences Group (NASDAQ:SLS) Shares Down 6.5% - Here's What HappenedJuly 16, 2026 | marketbeat.comSLS stock jumps overnight after new investor disclosure – retail flags ‘massive’ options bet ahead of AML dataJuly 14, 2026 | msn.comSELLAS Life Sciences: Strong Buy-Imminent Catalyst, Dual-Platform Pipeline, And A Market That Hasn't Caught UpJuly 14, 2026 | seekingalpha.comInvestors Purchase High Volume of Call Options on SELLAS Life Sciences Group (NASDAQ:SLS)July 13, 2026 | marketbeat.comSellas Life Sciences: REGAL Trial's Delayed Events Signal Selection BiasJuly 9, 2026 | seekingalpha.comHere’s Why SELLAS (SLS) is Among the 10 Best Performing American Stocks in June 2026July 9, 2026 | finance.yahoo.comSLS stock in the spotlight as CEO pushes back on Regal trial criticism – 'Let's separate the noise from the data'July 8, 2026 | msn.comMost and least shorted mid- to mega-cap healthcare stocks at the end of JuneJuly 1, 2026 | seekingalpha.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimePYR, BHC, AUP, and SLS Company DescriptionsAurinia Pharmaceuticals TSE:AUPAurinia Pharmaceuticals Inc., a biopharmaceutical company, develops and commercializes therapies to treat various diseases with unmet medical need in Japan and China. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license agreement with Otsuka Pharmaceutical Co., Ltd. The company is headquartered in Victoria, Canada.Bausch Health Cos NYSE:BHC$4.42 -0.03 (-0.56%) Closing price 07/24/2026 03:59 PM EasternExtended Trading$4.42 0.00 (0.00%) As of 07/24/2026 07:34 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Bausch Health Companies Inc. operates as a diversified specialty pharmaceutical and medical device company in the United States and internationally. It develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, international pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health. The company operates through five segments: Salix, International, Solta Medical, Diversified, and Bausch + Lomb. The Salix segment provides gastroenterology products in the United States. The International segment sells aesthetic medical devices, branded pharmaceuticals, generic pharmaceuticals, and OTC products internationally. The Solta Medical segment engages in the sale of aesthetic medical devices. The Diversified segment offers pharmaceutical products in the areas of neurology and certain other therapeutic classes; generic products; ortho dermatologic; and dentistry products in the United States. The Bausch + Lomb segment offers products in the areas of vision care, surgical, and ophthalmic pharmaceuticals products. The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. is headquartered in Laval, Canada.PyroGenesis Canada Inc. (PYR.V) CVE:PYRC$3.85 +0.38 (+10.95%) As of 11/19/2020PyroGenesis Canada Inc. designs, develops, manufactures, and commercializes advanced plasma processes and systems in Canada and internationally. It offers DROSRITE, a sustainable process for enhancing metal recovery from dross targeting primarily metallurgical industry; plasma atomized metal powders; PUREVAP, a process to produce high purity metallurgical grade silicon and solar grade silicon from quartz; plasma fired steam generator, which directly generates steam suitable for steam-assisted gravity drainage (SAGD) for the oil and gas industry; and custom reactors and furnaces for use in advanced materials, metallurgical, environmental, and chemical fields. The company also provides plasma torches, including APT for waste treatment, gas heating, research and development, and advanced materials production applications; Minigun, which offers a solution for thermal treatment of metals, nanotechnology, and material fabrication; reverse polarity torches for use in the production of high purity materials and nanomaterials, research and development, waste treatment, and thermal spray coatings; and SPT plasma torches for use in the destruction of refrigerants and other substances. In addition, it offers plasma arc gasification and vitrification system; plasma arc waste destruction system for land; plasma arc waste destruction system; PRRS, a plasma waste-to-energy solution; SPARC, a process for the destruction of ozone depleting substances and other environmentally noxious chemicals; and tactical PACWADS system that destroys chemical warfare agents. The company serves defense, metallurgical, mining, advanced materials, oil and gas, and environmental industries. PyroGenesis Canada Inc. is based in Montréal, Canada.SELLAS Life Sciences Group NASDAQ:SLS$11.32 -1.02 (-8.27%) Closing price 07/24/2026 04:00 PM EasternExtended Trading$11.36 +0.04 (+0.35%) As of 07/24/2026 07:34 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.SELLAS Life Sciences Group, Inc., a late-stage clinical biopharmaceutical company, focuses on the development of novel cancer immunotherapies for various cancer indications in the United States. The company's lead product candidate is galinpepimut-S (GPS), a cancer immunotherapeutic agent that targets Wilms tumor 1, which is in Phase 3 clinical trials for the treatment of acute myeloid leukemia; and in Phase 1/2 clinical trials for the treatment for ovarian cancer. It has a strategic collaboration with Merck & Co., Inc. to evaluate GPS as it is administered in combination with PD1 blocker pembrolizumab in a Phase 1/2 clinical trial enrolling patients in up to five cancer indications, including hematologic malignancies and solid tumors; and GenFleet Therapeutics (Shanghai), Inc. for the development and commercialization of GFH009, a highly selective small molecule CDK9 inhibitor, currently under Phase 1 clinical trials. SELLAS Life Sciences Group, Inc. is headquartered in New York, New York. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 07/20- 07/24 AMD and Cerbras Create A New Blueprint For Hardware Intel Earnings Reveal Whether the Chip Selloff Created a Buy CrowdStrike’s Cerebras Deal Puts Its AI Security Strategy to the Test Freeport McMoRan Post-Earnings: Why Good Enough May Finally Be Good Enough Tesla Just Delivered Record Sales—So Why Did the Stock Sell Off? Plugging In: How Kinder Morgan Powers Up Profits TSMC’s Price Hikes Could Show Which AI Chip Stocks Have Real Pricing Power Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
